Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2019

View Archived Issues

Identification of a novel target for the development of stroke treatments

Hitgen, Sun Pharma Advanced Research enter DEL-based drug discovery collaboration

Gene editing alleviates AD deficits in mouse models

China's NMPA clears HDAC6 inhibitor CS-3003 for phase I trials

Runx2 as a new target in chronic rhinosinusitis with neo-osteogenesis

AAV delivery of EPO-R76E delays retinal degeneration in a mouse model of geographic atrophy

Discovery of the first selective inhibitor of group XVI phospholipase A2

ACAM is a potential molecular target for treating multiple sclerosis

Identification of pyrrolidine amide derivatives as novel N-acylethanolamine acid amidase inhibitors

Results on safety, tolerability and pharmacokinetics of benapenem in healthy volunteers

Discovery of a druggable mechanism underlying tumorigenesis in ovarian cancer

RGC-32 as new target in chronic multiple sclerosis

Apelin receptor agonists identified at Bristol-Myers Squibb

Amgen presents new Mcl-1 inhibitors

Identification of a biomarker of inflammatory bowel disease severity

Wee1-like protein kinase inhibitors patented by Shanghai De Novo Pharmatech

Selection Bioscience discloses androgen receptor antagonists

Development of a novel, selective, kappa-opioid receptor antagonist

JS Innopharm patents ERK-2 inhibitors

AbbVie initiates phase I study of alpha-synuclein-targeting antibody ABBV-0805 for Parkinson's

Kyowa Hakko Kirin begins phase I study of KHK-4323 for atopic dermatitis

LRP-1 targeting confers retinal neuroprotection in diabetic mice

Phase III VELOS-2 trial explores use of HL-036 in patients with dry eye

BrainStorm initiates phase II study of MSC-NTF cells in progressive MS

Biohaven initiates phase III trial of troriluzole for spinocerebellar ataxia

Infinity and Roche enter master clinical supply agreement for MARIO-3 combination trial of IPI-549

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...